Pipobroman
Chemical compound
- L01AX02 (WHO)
- 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
- 54-91-1 Y
- 4842
- 7271
- DB00236 Y
- 4676 Y
- 6Q99RDT97R
- D00467 Y
- CHEBI:8242
- ChEMBL1585 Y
- DTXSID7023485
- Interactive image
- O=C(N1CCN(C(=O)CCBr)CC1)CCBr
InChI
- InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 Y
- Key:NJBFOOCLYDNZJN-UHFFFAOYSA-N Y
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent,[1] and is marketed in France and Italy.[2]
References
- v
- t
- e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
(M phase)
Block microtubule assembly | |
---|---|
Block microtubule disassembly |
inhibitor
DNA precursors/ antimetabolites (S phase) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Topoisomerase inhibitors (S phase) |
| ||||||||
Crosslinking of DNA (CCNS) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e